跳至主要内容
临床试验/NCT05004701
NCT05004701终止不适用

Impact of the Lockdown Due to the COVID Pandemic in French Wilson's Disease Patients

Fondation Ophtalmologique Adolphe de Rothschild1 个研究点 分布在 1 个国家目标入组 120 人开始时间: 2020年4月29日最近更新:
适应症

试验速览

阶段
不适用
状态
终止
入组人数
120
试验地点
1
主要终点
Quality of life was measured using the World Health Organization Quality of Life-BREF (WHOQOL-BREF) questionnaire

研究概览

简要总结

Wilson's disease is a rare genetic disorder that causes copper to build up in the body. This overload is initially localized in the liver and the brain, but can spread throughout the body and cause systemic damage if copper chelation or zinc salt therapy is not implemented quickly. Treatment should be taken daily and continued all the lifelong.

Patients usually have a follow-up (clinical examination, ultrasound of the liver, blood and urine samples) every six months in the maintenance phase of the disease and more frequently in the event of destabilization of the disease which requires adaptation of the doses of treatment or when initiating treatment. Some patients also benefit from regular psychological follow-up and patients with a disabling neurological form may have physiotherapy, and speech therapy. The Covid 19 pandemic has imposed the lockdown of the entire population, including patients with Wilson's disease. The non-urgent care of these patients was therefore suspended. Medical consultations and paramedical care (physiotherapy, speech therapy, psychologist, etc.) have been postponed. Only very urgent hospitalizations in the event of imbalance of their illness with life-threatening risk were maintained.

Wilson's disease patients could in this situation be particularly anxious and present disturbances of their quality of life. The psychiatric consequences could not be limited to the current period but also concern long-term patients, in particular if there is a worsening of the disease. The consequences of inactivity and the end of specific treatments (physiotherapy and speech therapy) could also be sources of aggravation. The behavioral and cognitive characteristics of the disease and the major difficulties in adherence to treatment already observed in this chronic disease, may suggest a repercussion of the pandemic in this population.

The consequences of the COVID pandemic in these fragile patients with a rare disease must be assessed. It will be important to look at the consequences of the lockdown on the adherence to treatment and on the course of the disease.

详细描述

During the lockdown period, the first part of a detailed questionnaire is proposed to Wilson's disease patients. The second part of the questionnaire will be carried out away from the lockdown This is an observational, French multicenter study, of an uncontrolled cohort of Wilsonian patients followed by doctors from the Wilson national reference centers

Intervention 1:

Other: Questionnaires The questionnaires are WHOQOL-BREF (quality of life) Compliance questionnaire with a Visual Analog Scale (VAS) from 0 to 100 Hospital Anxiety and Depression scale (HAD)

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
12 Years 至 —(Child, Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Wilson's disease patient
  • Patient over 12 years of age
  • Patient followed by doctors from the Wilson national reference centers (Paris, Lyon, Toulouse, Besançon, Bordeaux, Rennes, Marseilles, Tours, Lille )
  • Patients hospitalized or seen in outpatient consultation (or teleconsultation) during the first confinement and at the end of the last one
  • Non-opposition of participation in the study and for minor patient non-opposition of one of the two holders of the exercise of parental authority
  • Exclusion criteria :
  • Patient subject to a legal protection (tutorship)
  • Patient or patient representative not wishing to answer questions

排除标准

  • 未提供

结局指标

主要结局

Quality of life was measured using the World Health Organization Quality of Life-BREF (WHOQOL-BREF) questionnaire

时间窗: 6 months

To describe the quality of life of Wilsonian patients during the COVID lockdown and at short and long term after it. Quality of life was measured using the WHOQOL-BREF questionnaire The WHOQOL-BREF is a self-administered questionnaire comprising 26 questions on the individual's perceptions of their health and well-being over the previous two weeks. Responses to questions are on a 1-5 Likert scale where 1 represents "disagree" or "not at all" and 5 represents "completely agree" or "extremely". Thethe World Health Organization Quality of Life-BREF ( WHOQOL-BREF ) covers four domains each with specific facets

次要结局

未报告次要终点

研究者

申办方类型
Network
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验

Impact of the Lockdown Due to the COVID Pandemic in... | 临床试验